Literature DB >> 12857057

Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus.

Takashiro Suzuki1, Shinichiro Saito, Yasuhiko Hirabayashi, Hideo Harigae, Tomonori Ishii, Takao Kodera, Hiroshi Fujii, Yasuhiko Munakata, Takeshi Sasaki.   

Abstract

A 42-year-old woman with systemic lupus erythematosus (SLE) had an episode of fever, arthralgia and anemia. In order to treat the suspected activation of SLE, the daily dose of steroid was increased, however, the anemia progressed and pancytopenia developed. Both IgM anti-B19 antibodies to human parvovirus B19 (B19) and B19 DNA were positive, and bone marrow analysis revealed pure red cell aplasia with giant proerythroblasts. High dose gamma globulin was administered and the daily dose of steroid was tapered, resulting in the improvement of her condition. B19 infection should be ruled out in cases with reactivation of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857057     DOI: 10.2169/internalmedicine.42.538

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.

Authors:  Haruko Ideguchi; Shigeru Ohno; Yoshiaki Ishigatsubo
Journal:  Rheumatol Int       Date:  2006-10-07       Impact factor: 2.631

2.  Cyclosporine A responsive pure red cell aplasia in a child with systemic lupus erythematosus.

Authors:  Niranjan Biswal; Parameswaran Narayanan; Ginigeri Chetan
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

3.  Does parvovirus infection have a role in systemic lupus erythematosus?

Authors:  Tami Hod; Giselle Zandman-Goddard; Pnina Langevitz; Hagit Rudnic; Zehava Grossman; Pnina Rotman-Pikielny; Yair Levy
Journal:  Immunol Res       Date:  2017-04       Impact factor: 4.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.